⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6395191 | 1.00 | — | — | |
| SCHEMBL9119238 | 0.97 | GAA (0.31) | — | |
| SCHEMBL2657134 | 0.97 | GAA (0.31) | — | |
| SCHEMBL18659636 | 0.89 | — | — | |
| SCHEMBL18655451 | 0.84 | — | — | |
| SCHEMBL18659634 | 0.84 | — | — | |
| SCHEMBL2657412 | 0.82 | POLB (0.31) | — | |
| SCHEMBL17309260 | 0.80 | GBA1 (0.30) | — | |
| SCHEMBL16808531 | 0.78 | TLR9 (0.43) | — | |
| SCHEMBL16808415 | 0.78 | TLR9 (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170079928-A1 | COPOLYMERS OF FORMULA (I) AND USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2017-03-23 | — | — | US | disclosed |
| US-20170079928-A1 | COPOLYMERS OF FORMULA (I) AND USES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2017-03-23 | — | — | US | disclosed |
| WO-2015181504-A1 | COPOLYMERS OF FORMULA (I) AND USES | LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES (FR) | 2015-12-03 | — | — | WO | disclosed |
| US-4304931-A | ANTIINFLAMMATORY AGENTS | THE BOOTS COMPANY LIMITED (GB) | 1981-12-08 | — | — | US | disclosed |
| US-4188491-A | PREPARING 2-(4-BIPHENYLYL)PROPIONIC ACIDS BY REACTING BIPHENYLYLMAGNESIUM BROMIDES WITH SODIUM PYRUVATE, ACIDIFYING | THE BOOTS COMPANY LIMITED (GB) | 1980-02-12 | — | — | US | disclosed |